Tag: T1a RCC
CIRSE 2026: “COLLISION of the kidney” EuRECA registry reports five-year results
Five-year results from the prospective, multinational EuRECA registry support computed tomography (CT)-guided cryoablation for biopsy-proven T1a renal cell carcinoma (RCC), providing “benchmark” outcomes to...
Cryoablation gains ground as effective alternative treatment for T1a renal cell...
Interim analysis from the prospective multinational European Registry for Renal Cryoablation (EuRECA)—aimed to assess the oncological outcomes and safety profile of percutaneous cryoablation for...
New data find cryoablation “highly effective” in treatment of solitary renal...
A single-centre, retrospective review has reported 13-year data confirming cryoablation as a “highly effective” treatment modality for solitary T1a renal cell carcinoma (RCC) with...
